RecruitingNot Applicable

Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer

France200 participantsStarted 2021-02-12

Plain-language summary

This is a pilot, prospective, interventional, monocentric study designed to evaluate, in a real-life situation, adherence to tamoxifen treatment as a function of the taking of alternative and complementary therapies in patients with localized hormone-dependent breast cancer. 200 patients will be included in the study. Each patient will be followed for one day.

Who can participate

Age range18 Months

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age ≥ 18 years at entry into the study.
✓. Patient treated for hormone-dependent localized breast cancer requiring adjuvant Hormonal Therapy (HT) with tamoxifen.
✓. Patients treated with tamoxifen for a maximum of 1 to 3 years.
✓. Patient affiliated with a Social Security system in France.
✓. Patients who signed informed consent prior to inclusion in the study and prior to any specific study procedures.

Exclusion criteria

✕. Pregnant or breastfeeding women.
✕. Any psychological, family, geographical or sociological condition that does not allow the medical follow-up and/or the procedures foreseen in the study protocol to be respected.
✕. Patient who has forfeited his/her freedom by administrative or legal award or who is under legal protection (curatorship and guardianship, protection of justice).

What they're measuring

Rate of patients who adhere to tamoxifen treatment.

Timeframe: 18 months after the start of the research

Trial details

NCT IDNCT04740697

SponsorInstitut Claudius Regaud

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-02

Contact for this trial

Florence DALENC

05 31 15 51 04 dalenc.florence@iuct-oncopole.fr

View on ClinicalTrials.gov More Breast Cancer trials